Artificial Intelligence (AI) in Oncology Market Size & Growth Forecast 2027–2036, By Segments (Component Type, End Use Type, Cancer Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Artificial Intelligence in Oncology Market size was more than USD 8.3 billion in 2026 and is set to grow at a 23.56% CAGR between 2027 and 2036, attaining USD 68.84 billion by 2036. The industry revenue for 2027 is calculated at USD 9.95 billion.
Get more details on this report
Request Free Sample ReportArtificial Intelligence (AI) in Oncology Market Intelligence Snapshot
Regional Market Dynamics
- North America leads due to advanced clinical infrastructure, strong digital health integration, large oncology datasets, and wide AI imaging deployment, supported by collaboration moving tools into routine clinical use.
- Asia Pacific is projected at 31.13% CAGR, driven by rising healthcare digitization, expanded AI-assisted imaging adoption, and increasing oncology caseloads requiring improved efficiency and earlier diagnosis support.
Segment Momentum
- Hardware accounted for 41.8% of the market in 2026 because high-performance computing infrastructure, specialized processors, and reliable systems are essential for AI-enabled imaging, diagnostics, and real-time oncology data analysis.
- Software Solutions are growing fastest because healthcare providers seek scalable tools that improve diagnostic accuracy, treatment planning, and workflow efficiency while integrating more flexibly with existing oncology infrastructure.
Market Expansion Drivers
- Rising cancer incidence increasing demand for AI-enabled early diagnostic and screening platforms.
- Advancements in oncology imaging analytics improving precision cancer classification and treatment planning.
- Expanding hospital digitalization accelerating integration of AI-driven oncology decision support systems.
Leading Market Participants
- Prominent companies in the artificial intelligence in oncology market include GE HealthCare Technologies Inc. (United States), Siemens Healthineers AG (Germany), NVIDIA Corporation (United States), Intel Corporation (United States), PathAI, Inc. (United States), ConcertAI, LLC (United States), Median Technologies S.A. (France), iCAD, Inc. (United States), Azra AI, Inc. (United States), Digital Diagnostics Inc. (United States).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 8.3 billion
- 2027 Estimated Market Size: USD 9.95 billion.
- Projected Market Size: USD 68.84 billion by 2036
- Growth Forecast: 23.56% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hardware (Component Type) | Hospitals (End Use Type) | Breast Cancer (Cancer Type) | Diagnostics (Application)
- Emerging Opportunity Segment: Software Solutions (Component Type) | Hospitals (End Use Type) | Prostate Cancer (Cancer Type) | Research & Development (Application)
Market Growth Drivers and Industry Trends
Rising cancer incidence increasing demand for AI-enabled early diagnostic and screening platforms
Rising cancer incidence will drive the artificial intelligence in oncology market growth by increasing the need for faster and more accurate approaches to screening and early disease detection. AI-enabled platforms can process large volumes of medical images, patient records, and diagnostic information to identify patterns that may be difficult to detect through conventional assessment alone. Earlier identification can support timely clinical evaluation and improve the prioritization of patients requiring further diagnostic investigation, particularly across healthcare systems managing growing oncology workloads.
Advancements in oncology imaging analytics improving precision cancer classification and treatment planning
Advancements in medical imaging are strengthening the artificial intelligence in oncology market as AI algorithms increasingly support detailed analysis of tumor characteristics and disease patterns. Imaging analytics can assist clinicians in distinguishing lesions, assessing disease progression, and extracting clinically relevant information from complex scans, which can contribute to more consistent cancer classification. These capabilities also support treatment planning by helping oncology teams evaluate disease characteristics and integrate imaging-derived insights into individualized clinical decision-making.
Expanding hospital digitalization accelerating integration of AI-driven oncology decision support systems
The artificial intelligence in oncology market is gaining momentum as hospitals expand digital infrastructure and connect clinical data across diagnostic and treatment workflows. Digitized medical records, imaging systems, laboratory information, and clinical databases provide the data foundation required for AI-based decision support tools to operate within oncology settings. Integration of these systems can help clinicians review patient information more efficiently, identify relevant clinical patterns, and support treatment decisions while maintaining professional oversight in complex cancer care environments.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising cancer incidence increasing demand for AI-enabled early diagnostic and screening platforms | 2.00% | High | North America, Europe, Asia Pacific | High | Near Term |
| Advancements in oncology imaging analytics improving precision cancer classification and treatment planning | 1.80% | Moderate | North America, Asia Pacific | High | Mid Term |
| Expanding hospital digitalization accelerating integration of AI-driven oncology decision support systems | 1.40% | Moderate | Europe, Asia Pacific, Latin America | Emerging | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
In the artificial intelligence in oncology market, North America held the largest regional position in 2026, supported by advanced healthcare infrastructure, strong adoption of digital health technologies, and substantial investment in cancer research and precision medicine. The region benefits from widespread integration of AI-enabled tools across medical imaging, pathology, clinical decision support, drug discovery, and patient risk assessment. The availability of extensive clinical datasets and sophisticated data management capabilities further supports the development and validation of oncology-focused AI applications. Healthcare providers are increasingly using intelligent systems to improve diagnostic accuracy, identify clinically relevant patterns, personalize treatment strategies, and streamline complex workflows. Favorable investment conditions, established regulatory frameworks for medical technologies, and growing collaboration between healthcare institutions and technology developers are also strengthening the regional ecosystem. In addition, increasing demand for earlier cancer detection and more individualized care is encouraging healthcare organizations to adopt AI solutions that can complement clinical expertise and improve operational efficiency.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is emerging as the fastest-growing region, driven by expanding healthcare digitization, rising cancer care requirements, and increasing investments in advanced medical technologies. Improvements in hospital infrastructure and growing access to digital diagnostic platforms are creating opportunities for AI-based applications across imaging, pathology, treatment planning, and patient monitoring. Several healthcare systems in the region are also pursuing technology-enabled approaches to address growing clinical workloads and improve access to specialized oncology expertise. Increasing availability of electronic health data, cloud-based healthcare infrastructure, and computational capabilities is supporting broader experimentation and deployment of AI solutions. At the same time, greater awareness of precision oncology and the need for efficient cancer screening and diagnosis are encouraging healthcare providers to evaluate intelligent technologies. The combination of expanding healthcare investment, digital transformation, and unmet demand for scalable oncology services provides a strong foundation for rapid regional development.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Diagnostic SupportGermany emphasizes artificial intelligence applications that strengthen diagnostic accuracy and pathology workflows within oncology practice. Healthcare providers in Germany increasingly adopt validated AI solutions that complement clinician expertise while supporting consistent treatment decision-making.
France 🇫🇷
Data-Driven Cancer CareFrance supports artificial intelligence adoption in oncology through clinical research, imaging innovation, and multidisciplinary care pathways. Healthcare providers in France increasingly evaluate AI tools that improve diagnostic consistency while complementing evidence-based oncology practice.
Italy 🇮🇹
Integrated Clinical AnalyticsItaly is incorporating artificial intelligence into oncology workflows to strengthen diagnostic evaluation and treatment planning across healthcare facilities. Organizations in Italy increasingly prioritize AI platforms that integrate with clinical systems while supporting efficient interpretation of complex oncology data.
Japan 🇯🇵
Imaging Analytics AdoptionJapan continues expanding artificial intelligence in oncology through advanced imaging analysis and early cancer detection initiatives. Medical institutions in Japan prioritize AI platforms that enhance diagnostic precision, improve workflow efficiency, and integrate effectively with existing hospital systems.
South Korea 🇰🇷
Digital Oncology PlatformsSouth Korea is accelerating the integration of artificial intelligence across oncology diagnostics, treatment planning, and hospital information systems. Technology developers increasingly collaborate with healthcare providers to deliver interoperable AI solutions that enhance clinical efficiency and patient management.
United States 🇺🇸
Clinical Decision IntelligenceThe U.S. artificial intelligence in oncology market focuses on integrating AI into clinical decision support, diagnostic imaging, and personalized treatment planning. Healthcare organizations continue expanding data-driven oncology platforms that improve workflow efficiency and multidisciplinary cancer care coordination.
Segment Leadership and Growth Trends
Artificial Intelligence (AI) in Oncology Market Share (%), by Component Type, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportComponent Type Segment Analysis: Hardware (Largest Segment) vs Software Solutions (Fastest-Growing Segment)
The hardware segment accounted for the largest share of the artificial intelligence (AI) in oncology market at 41.8% in 2026. AI-enabled oncology applications require computing infrastructure capable of processing complex medical images, clinical datasets, and other information-intensive workloads, making hardware an essential foundation for deployment. Increasing adoption of advanced imaging and computationally intensive diagnostic technologies is supporting demand for high-performance processing infrastructure. As healthcare organizations expand their digital capabilities, investment in the underlying hardware required to operate AI systems remains an important component of oncology technology deployment.
Software solutions are expected to be the fastest-growing component type, driven by the expanding use of AI for cancer detection, imaging analysis, treatment planning, clinical decision support, and patient data interpretation. Software can convert large and complex oncology datasets into actionable insights while supporting more efficient clinical workflows. Growing emphasis on precision medicine and data-driven cancer care is encouraging healthcare providers to integrate AI-based applications into existing systems, while continued advances in machine learning and analytical capabilities are broadening potential use cases.
End Use Type Segment Analysis: Hospitals (Largest & Fastest-Growing Segment)
Hospitals held the largest share of the artificial intelligence (AI) in oncology market at 50.88% in 2026 and are also expected to be the fastest-growing end-use segment. Hospitals generate and manage extensive clinical information across imaging, pathology, patient records, and treatment pathways, creating strong opportunities for AI-assisted analysis and decision support. The integration of AI can help oncology teams improve diagnostic workflows, identify clinically relevant patterns, and support more personalized treatment strategies. Growing adoption of precision oncology, digital health infrastructure, and advanced clinical analytics is strengthening the role of hospitals as major users of AI-based oncology technologies.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Component Type | Software Solutions, Hardware, Services | Hardware | Software Solutions |
| End Use Type | Hospitals, Surgical Centers & Medical Institutes, Others | Hospitals | Hospitals |
| Cancer Type | Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others | Breast Cancer | Prostate Cancer |
| Application | Diagnostics, Radiation Therapy, Research & Development, Chemotherapy, Immunotherapy | Diagnostics | Research & Development |
Competitive Landscape and Market Positioning
Prominent players in the artificial intelligence (AI) in oncology market:
1. GE HealthCare Technologies Inc. (United States)
2. Siemens Healthineers AG (Germany)
3. NVIDIA Corporation (United States)
4. Intel Corporation (United States)
5. PathAI Inc. (United States)
6. ConcertAI LLC (United States)
7. Median Technologies S.A. (France)
8. iCAD Inc. (United States)
9. Azra AI Inc. (United States)
10. Digital Diagnostics Inc. (United States)
The artificial intelligence (AI) in oncology market is transforming cancer diagnostics and treatment planning through advanced computational models. Increased use of intelligent systems is improving clinical decision-making accuracy. Expanding integration of AI tools within healthcare ecosystems is enhancing workflow efficiency, while ongoing research is driving improvements in predictive oncology applications.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| GE HealthCare Technologies Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| NVIDIA Corporation (United States) | |||||||
| Intel Corporation (United States) | |||||||
| PathAI Inc. (United States) | |||||||
| ConcertAI LLC (United States) | |||||||
| Median Technologies S.A. (France) | |||||||
| iCAD Inc. (United States) | |||||||
| Azra AI Inc. (United States) | |||||||
| Digital Diagnostics Inc. (United States). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Clairity | Jun-25 | Clairity received U.S. FDA De Novo authorization for "CLAIRITY BREAST," an AI platform capable of predicting a woman’s five-year breast cancer risk directly from routine screening mammography, enhancing early intervention capabilities. |
| Univ. of Melbourne & Western Health | Jun-25 | Researchers developed "PredicTx," an AI-powered tool that analyzes CT scans to calculate body composition (fat, muscle, and bone ratio) to accurately predict and optimize chemotherapy dosing, minimizing toxicity. |
| Univ. Hospitals Cleveland | Apr-25 | The medical center activated a new AI-integrated program specifically designed to identify early-stage lung cancer nodules during low-dose CT screening workflows, improving diagnostic throughput. |
| Johns Hopkins | Apr-25 | Scientists developed a novel AI-based liquid biopsy technique that identifies specific DNA fragment patterns in blood circulation to non-invasively detect and characterize brain tumors. |
| iCAD | Apr-25 | iCAD integrated its "ProFound AI Breast Health Suite" into Microsoft’s Precision Imaging Network, providing cloud-based, scalable access for radiologists to enhance detection rates and reduce false positives. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Artificial Intelligence (AI) in Oncology Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Deployment Model | Cloud-Based, On-Premises, Hybrid |
| Data Modality | Medical Imaging Data, Clinical and Electronic Health Record Data, Genomic and Molecular Data, Pathology Data |
| User Type | Oncologists and Physicians, Pathologists and Radiologists, Researchers, Healthcare Administrators |
Artificial Intelligence (AI) in Oncology Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| AI-Driven Oncology Care Transformation Assessment |
|
| Precision Oncology Data Strategy Analysis |
|
| AI Regulatory and Validation Landscape |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of artificial intelligence (AI) in oncology?
What is the forecasted size of the artificial intelligence in oncology industry?
How is rising cancer incidence influencing purchasing priorities in the artificial intelligence (AI) in oncology market?
Why is hospital digitalization accelerating AI deployment across oncology workflows?
Why does hardware hold the largest share in the artificial intelligence (AI) in oncology market?
Why are Software Solutions the fastest-growing component in the artificial intelligence (AI) in oncology market?
Why does North America hold the largest share of the AI in oncology market?
What is driving Asia Pacific’s fastest growth in AI in oncology market?
Which companies dominate the artificial intelligence in oncology landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization